Tetrabenazine
Xenazine
Vesicular Monoamine Transporter 2 Inhibitor
NADAC/unit
$0.7854
No Shortage
Tier 1: 38.6%
PA Req: 176.3%
8 Manufacturers
15 ANDAs
indicated for the treatment of chorea associated with Huntington's disease.
vs. brand Xenazine: Generic saves up to 92% per unit
Generic Manufacturers
ACTAVIS LABORATORIES FL INCADAPTIS PHARMA PRIVATE LTDAPOTEX INCBAUSCH HEALTH US LLCBIONPHARMA INCCHARTWELL RX SCIENCES LLCDR REDDYS LABORATORIES LTDHETERO LABS LTD UNIT VMYLAN PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
